je.st
news
Tag: pozen
Pozen buying Canada's Tribute Pharmaceuticals for US$146 million
2015-06-08 22:49:01| Biotech - Topix.net
U.S. specialty drug company Pozen Inc. announced Monday that it plans to acquire Tribute Pharmaceuticals Canada in a deal valued at about US$146 million. After the acquisition, expected to be competed in the fourth quarter, the combined company will change its name to Aralez Pharmaceuticals PLC and move its headquarters to Ireland to benefit from lower corporate tax rates in that country.
Tags: million
buying
tribute
pharmaceuticals
POZEN (POZN) Issues Quarterly Earnings Results
2015-05-10 05:11:59| Biotech - Topix.net
POZEN posted its quarterly earnings results on Friday. The company reported $0.01 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.05 by $0.04, AnalystRatingsNetwork reports.
Tags: results
issues
quarterly
earnings
Insider Selling: John R. Plachetka Unloads 50,000 Shares of POZEN Stock
2014-10-11 14:12:11| Biotech - Topix.net
POZEN CEO John R. Plachetka sold 50,000 shares of POZEN stock in a transaction that occurred on Thursday, October 9th. The stock was sold at an average price of $8.12, for a total transaction of $406,000.00.
Tags: john
stock
selling
shares
POZEN Rating Increased to Buy at Ascendiant Capital Markets
2014-08-09 22:40:07| Biotech - Topix.net
The firm currently has a $10.00 price target on the stock. Ascendiant Capital Markets' price target would suggest a potential upside of 22.25% from the company's current price.
Tags: buy
rating
capital
increased
Insider Selling: Arthur S. Kirsch Sells 2,500 Shares of POZEN Stock
2014-06-09 06:19:47| Biotech - Topix.net
POZEN Director Arthur S. Kirsch sold 2,500 shares of the stock in a transaction dated Thursday, June 5th.
Tags: stock
selling
shares
arthur